Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals
AssigneeSociete L'Oreal S.A.
InventorsAlvin Berger, Andre Jomard
Life of this patent
Estimating the term…
Abstract
The invention concerns fatty acids uninterrupted by a methylene group as anti-inflammatory agents in superficial tissues of mammals, more particularly a pharmaceutical or cosmetic topical composition comprising, as an active ingredient, at least one fatty acid uninterrupted by a methylene group corresponding to formula (I), an salt or ester thereof, wherein R1 is a C1-C5 alkyl group and R2 is a C2-C6 alkyl group. Preferably, the fatty acid uninterrupted by a methylene group is 20:3(5,11,14). The fatty acid uninterrupted by a methylene group is also used for preparing a composition for modulating the metabolism of lipids in the superficial tissue of mammals.
Claims22
A topical pharmaceutical or cosmetic composition comprising, as an active ingredient, at least one substance selected from the group consisting of non-methylene-interrupted fatty acids having formula (I), salts and esters thereof, along with a carrier for transporting the active ingredient into a superficial mammalian tissue,
- wherein R1 is a C1-C5 alkyl group and R2 is a C2-C6 alkyl group.
A pharmaceutical, food or cosmetic composition, comprising a combination of a fish oil and at least one substance selected from the group consisting of non-methylene-interrupted fatty acids of formula (I),
- salts and esters thereof, wherein R1 is a C1-C5 alkyl group and R2 is a C2-C6 alkyl group.
A method to modulate the metabolism of lipids in superficial mammalian tissues comprising administering an effective amount of at least one substance selected from the group consisting of non-methylene-interrupted fatty acids of formula (I), salts and esters thereof to a mammal in need of such modulation,
- wherein R1 is a C1-C5 alkyl group and R2 is a C2-C6 alkyl group.
A method to treat or prevent inflammation in superficial mammalian tissues comprising administering an effective amount of at least one substance selected from the group consisting of non-methylene-interrupted fatty acids of formula (I), salts and esters thereof to a mammal in need of such treatment of prevention,
- wherein R1 is a C1-C5 alkyl group and R2 is a C2-C6 alkyl group.
Dependencies are inferred from the claim text.